SEC 13F Intelligence

ACHILLION PHARMACEUTICALS IN

CUSIP 00448Q201

Achillion Pharmaceuticals In has 1 institutional holders in Filings Flow’s 13F database, together reporting 900 shares worth $3,789 as of Q2 2024.

Institutional Holders
1
Q2 2024
Reported Value
$3,789
Ticker
unmapped
private placement or foreign
Quarters Tracked
12

Ownership Trend

Institutional holders
Q4 ’18: 92Q4 ’18Q1 ’19: 88Q2 ’19: 92Q2 ’19Q3 ’19: 101Q4 ’19: 113Q4 ’19Q1 ’20: 3Q2 ’20: 2Q2 ’20Q3 ’20: 2Q4 ’20: 1Q4 ’20Q1 ’21: 1Q2 ’21: 1Q2 ’21Q2 ’24: 1filingsflow.com
Total reported value
Q4 ’18: $87MQ4 ’18Q1 ’19: $169MQ2 ’19: $156MQ2 ’19Q3 ’19: $220MQ4 ’19: $508MQ4 ’19Q1 ’20: $102,000Q2 ’20: $92,000Q2 ’20Q3 ’20: $124,000Q4 ’20: $0Q4 ’20Q1 ’21: $0Q2 ’21: $0Q2 ’21Q2 ’24: $3,789filingsflow.com

Holders

Export to Excel
Manager% of PortfolioValueSharesQuarter
Federation des caisses Desjardins du Quebec$27.8B AUM0.00%$3,789900Q2 2024

Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.